7-104166864-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002553.4(ORC5):c.898G>T(p.Val300Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000385 in 1,606,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002553.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ORC5 | NM_002553.4 | c.898G>T | p.Val300Leu | missense_variant | 10/14 | ENST00000297431.9 | |
ORC5 | XM_047420431.1 | c.*44G>T | 3_prime_UTR_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ORC5 | ENST00000297431.9 | c.898G>T | p.Val300Leu | missense_variant | 10/14 | 1 | NM_002553.4 | P1 | |
ORC5 | ENST00000422497.5 | c.*831G>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/15 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000295 AC: 74AN: 250676Hom.: 0 AF XY: 0.000258 AC XY: 35AN XY: 135438
GnomAD4 exome AF: 0.000403 AC: 586AN: 1454162Hom.: 0 Cov.: 27 AF XY: 0.000413 AC XY: 299AN XY: 723876
GnomAD4 genome AF: 0.000210 AC: 32AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.898G>T (p.V300L) alteration is located in exon 10 (coding exon 10) of the ORC5 gene. This alteration results from a G to T substitution at nucleotide position 898, causing the valine (V) at amino acid position 300 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at